EA201692531A1 - Способы лечения инфекций - Google Patents
Способы лечения инфекцийInfo
- Publication number
- EA201692531A1 EA201692531A1 EA201692531A EA201692531A EA201692531A1 EA 201692531 A1 EA201692531 A1 EA 201692531A1 EA 201692531 A EA201692531 A EA 201692531A EA 201692531 A EA201692531 A EA 201692531A EA 201692531 A1 EA201692531 A1 EA 201692531A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- days
- treating infections
- treating
- risk
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Настоящее изобретение относится к способам лечения, профилактики или снижения риска микробных инфекций, минимизируя при этом нежелательные побочные желудочно-кишечные эффекты, с использованием двухстадийного режима дозирования, включающего внутривенное введение от приблизительно 1 до приблизительно 7 дней, с последующим пероральным введением в течение от приблизительно 1 до приблизительно 14 дней антимикробного средства.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462014790P | 2014-06-20 | 2014-06-20 | |
US201462034468P | 2014-08-07 | 2014-08-07 | |
PCT/US2015/036699 WO2015196076A1 (en) | 2014-06-20 | 2015-06-19 | Methods for treating infections |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201692531A1 true EA201692531A1 (ru) | 2017-05-31 |
Family
ID=54868662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201692531A EA201692531A1 (ru) | 2014-06-20 | 2015-06-19 | Способы лечения инфекций |
Country Status (17)
Country | Link |
---|---|
US (2) | US20150366858A1 (ru) |
EP (1) | EP3157633A4 (ru) |
JP (1) | JP2017518354A (ru) |
CN (1) | CN106687179A (ru) |
AU (1) | AU2015276911A1 (ru) |
BR (1) | BR112016029896A2 (ru) |
CA (1) | CA2952955A1 (ru) |
CL (1) | CL2016003271A1 (ru) |
EA (1) | EA201692531A1 (ru) |
EC (1) | ECSP16095557A (ru) |
IL (1) | IL249616A0 (ru) |
MX (1) | MX2016017348A (ru) |
PH (1) | PH12016502547A1 (ru) |
SV (1) | SV2016005348A (ru) |
TW (1) | TW201605447A (ru) |
UY (1) | UY36183A (ru) |
WO (1) | WO2015196076A1 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105693695A (zh) * | 2014-11-24 | 2016-06-22 | 重庆医药工业研究院有限责任公司 | 一种德拉沙星葡甲胺盐的晶型及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19814256A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
LT3056492T (lt) * | 2004-10-08 | 2022-01-25 | Abbvie Inc. | Meglumino druska ir atitinkamos vaisto (delafloksacino) kristalinės formos |
PT1868581E (pt) * | 2005-04-11 | 2012-06-22 | Abbott Lab | Composições farmacêuticas que possuem perfis de dissolução melhorados para fármacos pouco solúveis |
US20070249577A1 (en) * | 2005-05-10 | 2007-10-25 | Hopkins Scott J | Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures |
CN1943561A (zh) * | 2006-08-23 | 2007-04-11 | 北京阜康仁生物制药科技有限公司 | 普卢利沙星口腔崩解片及其制备方法 |
KR20170039758A (ko) * | 2008-09-24 | 2017-04-11 | 멜린타 테라퓨틱스, 인크. | 퀴놀론 화합물의 제조 방법 |
KR101767689B1 (ko) * | 2008-11-15 | 2017-08-11 | 멜린타 테라퓨틱스, 인크. | 항미생물 조성물 |
WO2010096551A2 (en) * | 2009-02-18 | 2010-08-26 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compositions |
WO2014152332A1 (en) * | 2013-03-15 | 2014-09-25 | Melinta Therapeutics, Inc. | Methods of treating infections in overweight and obese patients using antibiotics |
-
2015
- 2015-06-18 TW TW104119696A patent/TW201605447A/zh unknown
- 2015-06-19 CN CN201580044477.2A patent/CN106687179A/zh active Pending
- 2015-06-19 WO PCT/US2015/036699 patent/WO2015196076A1/en active Application Filing
- 2015-06-19 US US14/744,671 patent/US20150366858A1/en not_active Abandoned
- 2015-06-19 JP JP2016574152A patent/JP2017518354A/ja active Pending
- 2015-06-19 EP EP15810585.8A patent/EP3157633A4/en not_active Withdrawn
- 2015-06-19 BR BR112016029896A patent/BR112016029896A2/pt not_active IP Right Cessation
- 2015-06-19 MX MX2016017348A patent/MX2016017348A/es unknown
- 2015-06-19 AU AU2015276911A patent/AU2015276911A1/en not_active Abandoned
- 2015-06-19 EA EA201692531A patent/EA201692531A1/ru unknown
- 2015-06-19 CA CA2952955A patent/CA2952955A1/en not_active Abandoned
- 2015-06-22 UY UY0001036183A patent/UY36183A/es not_active Application Discontinuation
-
2016
- 2016-12-18 IL IL249616A patent/IL249616A0/en unknown
- 2016-12-20 PH PH12016502547A patent/PH12016502547A1/en unknown
- 2016-12-20 CL CL2016003271A patent/CL2016003271A1/es unknown
- 2016-12-20 SV SV2016005348A patent/SV2016005348A/es unknown
- 2016-12-20 EC ECIEPI201695557A patent/ECSP16095557A/es unknown
-
2017
- 2017-09-06 US US15/696,603 patent/US20170368055A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TW201605447A (zh) | 2016-02-16 |
IL249616A0 (en) | 2017-02-28 |
WO2015196076A1 (en) | 2015-12-23 |
EP3157633A4 (en) | 2018-02-21 |
BR112016029896A2 (pt) | 2017-08-22 |
AU2015276911A2 (en) | 2018-04-26 |
ECSP16095557A (es) | 2017-03-31 |
JP2017518354A (ja) | 2017-07-06 |
MX2016017348A (es) | 2017-04-06 |
SV2016005348A (es) | 2017-03-02 |
EP3157633A1 (en) | 2017-04-26 |
PH12016502547A1 (en) | 2017-04-10 |
CA2952955A1 (en) | 2015-12-23 |
US20150366858A1 (en) | 2015-12-24 |
UY36183A (es) | 2016-01-29 |
US20170368055A1 (en) | 2017-12-28 |
CL2016003271A1 (es) | 2017-08-04 |
CN106687179A (zh) | 2017-05-17 |
AU2015276911A1 (en) | 2017-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501750A1 (en) | Human plasma kallikrein inhibitors | |
PH12018500065A1 (en) | Oxysterols and methods of use thereof | |
TW201613887A (en) | Antiproliferative compounds and methods of use thereof | |
EA201791420A1 (ru) | Соединения триазолопиримидина и их применения | |
NZ730809A (en) | Methods for treating filoviridae virus infections | |
PH12018500061A1 (en) | Oxysterols and methods of use thereof | |
EA201790726A1 (ru) | Фармацевтическая композиция для лечения язвенного колита | |
EA201790442A1 (ru) | Трициклические азотсодержащие соединения для лечения инфекции, вызываемой neisseria gonorrhoeae | |
BR112018074985A2 (pt) | composições antibacterianas | |
MX2017012073A (es) | Compuestos de minociclina para biodefensas. | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
PH12018500358A1 (en) | Compounds for use in an antibacterial applications | |
WO2015001541A3 (en) | Pharmaceutical film composition | |
WO2016020408A3 (en) | Compounds for preventing ototoxicity | |
PH12016502547A1 (en) | Methods for treating infections | |
PH12016502548A1 (en) | Antimicrobial compositions with effervescent agents | |
EA201792265A1 (ru) | Способы лечения сердечно-сосудистых заболеваний | |
CR20160591A (es) | Metodos para tratar infecciones | |
BR112016024236A2 (pt) | composições farmacêuticas compreendendo agentes antibacterianos | |
AR115865A2 (es) | Compuestos terapéuticos | |
MX2015003939A (es) | Combinacion y composicion farmaceutica que contiene un antimicrobiano y un antimicotico. | |
TH171202A (th) | สารประกอบและวิธีการสำหรับการรักษาการติดเชื้อแบคทีเรีย | |
EA201390764A1 (ru) | Фармацевтические композиции |